Back to JNJ
Compagnie Lombard Odier SCmA → JNJ
Compagnie Lombard Odier SCmA JNJ Position History
Johnson & Johnson • Healthcare
Quarters held
16
Latest value
$2.6M
Q3 2026
Peak value
$109M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $376K |
| Q3 2025 | $63.4M |
| Q3 2025 | $471K |
| Q4 2025 | $420K |
| Q4 2025 | $77M |
| Q4 2025 | $569K |
| Q1 2026 | $496K |
| Q1 2026 | $87.1M |
| Q1 2026 | $1.7M |
| Q2 2026 | $1M |
| Q2 2026 | $91.9M |
| Q2 2026 | $2.4M |
| Q3 2026 | $72K |
| Q3 2026 | $1.6M |
| Q3 2026 | $109M |
| Q3 2026 | $2.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.6M | 10.0K | — | — |
| Q3 2026 | $109M | 411.7K | — | — |
| Q3 2026 | $1.6M | 6.1K | — | — |
| Q3 2026 | $72K | 856 | — | — |
| Q2 2026 | $2.4M | 9.4K | — | — |
| Q2 2026 | $91.9M | 361.7K | — | — |
| Q2 2026 | $1M | 4.1K | — | — |
| Q1 2026 | $1.7M | 7.0K | — | — |
| Q1 2026 | $87.1M | 356.2K | — | — |
| Q1 2026 | $496K | 2.0K | — | — |
| Q4 2025 | $569K | 2.8K | — | — |
| Q4 2025 | $77M | 372.3K | — | — |
| Q4 2025 | $420K | 2.0K | — | — |
| Q3 2025 | $471K | 2.5K | — | — |
| Q3 2025 | $63.4M | 341.7K | — | — |
| Q3 2025 | $376K | 2.0K | — | — |